Gensight Biologics (XPAR:SIGHT) FCF Yield % : -61.65 (As of May. 21, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gensight Biologics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Gensight Biologics's Trailing 12-Month Free Cash Flow is €-24.66 Mil, and Market Cap is €40.00 Mil. Therefore, Gensight Biologics's FCF Yield % for today is -61.65%.

The historical rank and industry rank for Gensight Biologics's FCF Yield % or its related term are showing as below:

XPAR:SIGHT' s FCF Yield % Range Over the Past 10 Years
Min: -179.02 Med: -20.51 Max: -4.76
Current: -61.65

During the past 12 years, the highest FCF Yield % of Gensight Biologics was -4.76%. The lowest was -179.02%. And the median was -20.51%.

XPAR:SIGHT's FCF Yield % is ranked worse than
78.93% of 1557 companies
in the Biotechnology industry
Industry Median: -14.1 vs XPAR:SIGHT: -61.65

Gensight Biologics's FCF Margin % for the quarter that ended in Dec. 2023 was 2,987.63%.

Gensight Biologics FCF Yield % Historical Data

The historical data trend for Gensight Biologics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gensight Biologics FCF Yield % Chart

Gensight Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-34.57

-5.16

-6.68

-21.90

-82.56

Gensight Biologics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-5.41	-32.62	-22.12	-94.06	-56.59

Competitive Comparison of Gensight Biologics's FCF Yield %

For the Biotechnology subindustry, Gensight Biologics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gensight Biologics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gensight Biologics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Gensight Biologics's FCF Yield % falls into.

Gensight Biologics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Gensight Biologics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-24.673	/	29.884222
	=	-82.56%

Gensight Biologics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-8.455	*	2	/	29.884222
	=	-56.59%

Gensight Biologics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Gensight Biologics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Gensight Biologics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gensight Biologics (XPAR:SIGHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (XPAR:SIGHT) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

GSGTF:USA G49N:Germany

Address

74,rue du Faubourg Saint-Antoine, Paris, FRA, 75012

Website

https://www.gensight-biologics.com

Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence, and Optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group focus is on ophthalmology where it develops product candidates to restore eyesight to patients suffering from retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.

Gensight Biologics (XPAR:SIGHT) Headlines

No Headlines